Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer
Clinical trial comparing Fujifilm DBT Plus S-View with FFDM alone for detection of breast cancer; study completed with results posted in 202…
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Multi-Reader Multi-Case Controlled Clinical Trial to Assess the Fujifilm FFDM and DBT Reader Training Program [NA]
A completed multi-reader, multi-case trial evaluating the Fujifilm FFDM and DBT reader training program for breast cancer imaging; results p…
-
FDA approval · 2020-06-08FDA Approved: EVEROLIMUS — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s generic Everolimus under an Original Application, enabling the sale of a generic version of th…
-
CLINICAL_TRIALS trial_result · 2020-06-05Clinical Trial Update: Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating simvastatin in combination with neoadjuvant chemotherapy for locally advanced breast cancer to assess clinical resp…
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study
A pivotal study comparing Fujifilm DBT Plus S-View with FFDM alone for detecting breast cancer has completed and results were posted in 2020…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Pilot Mammography Reader Study to Assess Breast Cancer Detection in FFDM Plus DBT Versus FFDM Alone [NA]
Pilot reader study comparing breast cancer detection between FFDM with DBT versus FFDM alone; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy in combination with an IDO inhibitor for metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-05-27Clinical Trial Update: Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer [Phase 3]
Phase 3 clinical trial update evaluating the efficacy of metronomic capecitabine in triple-negative breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-05-27Clinical Trial Update: Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia [Phase 4]
Phase 4 trial update on agents for primary prophylaxis of febrile neutropenia in early stage breast cancer.
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer [Phase 2]
Phase 2 study of abemaciclib in women with HR+, HER2+ locally advanced or metastatic breast cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: Empowering Latinas to Obtain Breast Cancer Screenings [NA]
A completed clinical trial sponsored by the University of Illinois at Chicago focused on empowering Latinas to obtain breast cancer screenin…
-
CLINICAL_TRIALS trial_result · 2020-05-21Clinical Trial Update: Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate [Phase 3]
Phase 3 trial update evaluating palbociclib plus letrozole in postmenopausal women with HR-positive, HER2-negative advanced breast cancer fo…
-
CLINICAL_TRIALS trial_result · 2020-05-21Clinical Trial Update: A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1b/2 study evaluating serabelisib in combination with canagliflozin in advanced solid tumors; current status unclear.
-
CLINICAL_TRIALS trial_result · 2020-05-20Clinical Trial Update: Acquisition of Breast Mammography Images
Clinical trial update notes completion and results posting for a study on breast cancer imaging data acquisition.
-
CLINICAL_TRIALS trial_result · 2020-05-20Clinical Trial Update: Fujifilm Feature Comparison Reader Study to Compare Old vs New Processing
A completed clinical trial study comparing old vs new processing in mammography feature reader study for breast cancer.
-
FDA approval · 2020-05-19FDA Approved: MEGESTROL ACETATE — Supplemental Application (Strides Pharma Science Limited)
FDA approved Strides Pharma Science Limited's supplemental application for megestrol acetate.
-
CLINICAL_TRIALS trial_result · 2020-05-19Clinical Trial Update: Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy [Phase 3]
Phase 3 trial comparing minus anthracycline or short-term vs epirubicin and cyclophosphamide followed by paclitaxel for adjuvant therapy in …
-
CLINICAL_TRIALS trial_result · 2020-05-15Clinical Trial Update: A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib [Phase 3]
Clinical trial update for a Phase 3 study companion protocol exploring breast cancer aberrations with CDK4/6 inhibition (ribociclib) that ha…
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
Phase Ib/II trial evaluating PLX 3397 in combination with eribulin for metastatic breast cancer has completed with results posted.
-
FDA approval · 2020-05-13FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Faslodex (fulvestrant) by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC. [Phase 3]
A phase 3 trial evaluating the efficacy and safety of the combination of TQ-B211 with docetaxel in HER2-positive metastatic breast cancer is…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: A Study of HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 Alone [Phase 2]
Phase 2 trial evaluating afatinib plus T-DM1 versus T-DM1 alone in HER2-positive breast cancer with active brain metastases.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer [Phase 2]
Phase 2 trial evaluating zoledronate for treating bone marrow micrometastases in women with breast cancer (stages I–III).
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Comparing Effect of Adding Ketamine Versus Dexmedetomidine to Bupivacaine in Pec 11 Modified Block on Postoperative Pain Control in Patients Undergoing Breast Surgery [Phase 3]
Phase 3 trial updating the effect of adding ketamine versus dexmedetomidine to bupivacaine in a PEC 11 modified block for postoperative anal…
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Comparison of the Philips MicroDose Tomosynthesis System to 2D Digital Mammography [NA]
Clinical trial update on comparing the Philips MicroDose Tomosynthesis System to 2D digital mammography for breast cancer; study terminated …